Related Experiment Video
Updated: Mar 15, 2026
04:48
Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures
Published on: November 22, 2024
976
Inflammatory Biomarkers Profile as Microenvironmental Expression in Keratoconus
Catalina Ionescu1, Catalina Gabriela Corbu2, Cristiana Tanase3
1Clinical Hospital of Ophthalmologic Emergencies (SCUO), Piața Alexandru Lahovari 1, Bucharest, Romania.
Disease Markers
|August 27, 2016
Summary
Keratoconus, a corneal disorder causing vision loss, may involve inflammation. Recent research explores inflammatory biomarkers, pathways, and potential new treatments for this condition.
Area of Science:
- Ophthalmology
- Immunology
- Genetics
Background:
- Keratoconus is a progressive corneal disorder leading to vision impairment.
- Its exact cause is unknown, but genetic and environmental factors are implicated.
- Emerging research suggests a role for inflammation in keratoconus pathogenesis.
Purpose of the Study:
- To review recent literature on inflammatory biomarkers in keratoconus.
- To examine the signaling pathways involved in keratoconus inflammation.
- To discuss potential novel therapeutic strategies targeting inflammation in keratoconus.
Main Methods:
- Systematic review of published research papers.
- Analysis of studies identifying inflammatory biomarkers.
- Review of research on inflammatory signaling pathways.
- Evaluation of emerging therapeutic interventions.
Main Results:
- Several inflammatory biomarkers have been identified in keratoconus patients.
- Specific inflammatory signaling pathways are implicated in disease progression.
- Targeting inflammation presents promising therapeutic avenues.
Conclusions:
- Inflammation is a significant factor in keratoconus.
- Understanding inflammatory pathways can guide treatment development.
- Targeted anti-inflammatory therapies may offer new hope for keratoconus patients.
